Abstract
Integrating multifunctional nanostructures and effectively modulating the tumor microenvironment (TME) is a need for precision nanotherapy. In this work, cuprous iodide-palladium iodides (CPIs) nanoenzymes were designed for infrared thermal (IR) and computed tomography (CT) imaging-guided synergistic chemodynamic-photothermal therapy (CDT and PTT) of tumor. CPIs act as peroxidase (POD)-like enzymes to catalyze the generation of hydroxyl radicals (OH) from endogenous H2O2, and also reduce the excess glutathione (GSH) in the TME to relieve tumor antioxidant ability, which enhance the effect of CDT. More importantly, due to the promoted non-radiative recombination of carries, the CPIs shift the light absorption range to the near-infrared region and confer higher photothermal conversion efficiency (47.72%), which improves the photothermal therapeutic effect and accelerate the generation rate of OH. Furthermore, the CT images exhibited by CPIs can help guide synergistic CDT/PTT treatment due to the high X-ray attenuation coefficient of the I-element. Finally, based on the dual oxidation of Cu(Ⅰ) and I(Ⅰ), the CPIs can be degraded to avoid long-term toxicity after inhibiting tumor growth. All in all, this nanotherapeutic platform constructed by iodides provide a possibility to simultaneously meet the biodegradability and imaging-guided synergistic chemodynamic-photothermal therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
